These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 8760835)
1. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. D'Andrea A; Chang C; Phillips JH; Lanier LL J Exp Med; 1996 Aug; 184(2):789-94. PubMed ID: 8760835 [TBL] [Abstract][Full Text] [Related]
2. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB; Phillips JH; Figdor CG; Lanier LL J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119 [TBL] [Abstract][Full Text] [Related]
3. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Phillips JH; Gumperz JE; Parham P; Lanier LL Science; 1995 Apr; 268(5209):403-5. PubMed ID: 7716542 [TBL] [Abstract][Full Text] [Related]
4. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804 [TBL] [Abstract][Full Text] [Related]
5. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304 [TBL] [Abstract][Full Text] [Related]
6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
7. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor. Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681 [TBL] [Abstract][Full Text] [Related]
8. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j. Morel E; Bellón T J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926 [TBL] [Abstract][Full Text] [Related]
9. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697 [TBL] [Abstract][Full Text] [Related]
10. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286 [TBL] [Abstract][Full Text] [Related]
12. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. Kurago ZB; Lutz CT; Smith KD; Colonna M J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412 [TBL] [Abstract][Full Text] [Related]
13. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes. D'Orazio JA; Stein-Streilein J Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534 [TBL] [Abstract][Full Text] [Related]
14. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759 [TBL] [Abstract][Full Text] [Related]
15. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans. Moretta A; Ciccone E; Pantaleo G; Tambussi G; Bottino C; Melioli G; Mingari MC; Moretta L Immunol Rev; 1989 Oct; 111():145-75. PubMed ID: 2697680 [TBL] [Abstract][Full Text] [Related]
16. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. Moretta A; Sivori S; Vitale M; Pende D; Morelli L; Augugliaro R; Bottino C; Moretta L J Exp Med; 1995 Sep; 182(3):875-84. PubMed ID: 7650491 [TBL] [Abstract][Full Text] [Related]
17. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL J Exp Med; 1994 Aug; 180(2):537-43. PubMed ID: 8046332 [TBL] [Abstract][Full Text] [Related]
19. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Bonaparte MI; Barker E Blood; 2004 Oct; 104(7):2087-94. PubMed ID: 15117765 [TBL] [Abstract][Full Text] [Related]
20. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]